Showing results (51-60 of 217) with videos related to

Sort By:
Pageof 22
Lupus Science & Medicine|February 11, 2021
Efficacy of belimumab in two serologically distinct high disease activity subgroups of patients with systemic lupus erythematosus: post-hoc analysis of data from the phase III programmeToni Maslen, Ian N Bruce, David D'Cruz, et al.
Lupus Science & Medicine|December 15, 2017
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational surveyPintip Ngamjanyaporn, Eoghan M McCarthy, Jamie C Sergeant, et al.
RMD Open|July 30, 2020
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatmentJennifer C Davies, Angela Midgley, Emil Carlsson, et al.
Lupus|July 18, 2023
Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception CohortTrixy David, Li Su, Yafeng Cheng, et al.
Rheumatology Advances in Practice|October 26, 2022
The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patientsChee-Seng Yee, Munther Khamashta, Mohammed Akil, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 22, 2014
The effect of type 1 IFN on human aortic endothelial cell function in vitro: relevance to systemic lupus erythematosusJohn A Reynolds, David W Ray, Leo A H Zeef, et al.
Rheumatology (Oxford, England)|May 15, 2015
The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics eraCatharine Morgan, John McBeth, Lis Cordingley, et al.
Seminars in Arthritis and Rheumatism|June 13, 2017
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic reviewCarmelo Pirone, Claudia Mendoza-Pinto, Daniëlle A van der Windt, et al.
Journal of Comparative Effectiveness Research|May 13, 2022
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosusIan N Bruce, Sarowar Golam, Jason Steenkamp, et al.
American Journal of Medical Genetics. Part A|January 7, 2026
Noonan Syndrome Spectrum Disorders Predispose to Systemic Lupus Erythematosus: Case Report and Critical Review of the LiteratureAnastasia-Vasiliki Madenidou, Gillian I Rice, James O'Sullivan, et al.
Pageof 22